Prognostic value of MRI-derived residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma and a nomogram for the prediction of it

被引:0
|
作者
Li, W-Z. [1 ]
Liang, H. [1 ]
Lv, X. [1 ]
Ke, L-R. [2 ]
Ye, Y-F. [3 ]
Yu, Y-H. [1 ]
Qiu, W-Z. [1 ]
Liu, G-Y. [1 ]
Huang, X-J. [1 ]
Liu, K-Y. [1 ]
Lv, S-H. [1 ]
Guo, X. [1 ]
Xiang, Y-Q. [1 ]
Xia, W-X. [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Radiol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Mem Hosp, Clin Trial Design Div, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1095P
引用
收藏
页码:390 / 390
页数:1
相关论文
共 50 条
  • [1] MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it
    Li, Wang-Zhong
    Liu, Guo-Ying
    Lin, Lan-Feng
    Lv, Shu-Hui
    Qiang, Meng-Yun
    Lv, Xing
    Wu, Yi-Shan
    Liang, Hu
    Ke, Liang-Ru
    Wang, De-Ling
    Yu, Ya-Hui
    Qiu, Wen-Ze
    Liu, Kui-Yuan
    Guo, Xiang
    Li, Jian-Peng
    Zou, Yu-Jian
    Xiang, Yan-Qun
    Xia, Wei-Xiong
    RADIOTHERAPY AND ONCOLOGY, 2020, 145 : 101 - 108
  • [2] Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
    Tang, Ling-Long
    Guo, Rui
    Zhou, Guanqun
    Sun, Ying
    Liu, Li-Zhi
    Lin, Ai-Hua
    Mai, Haiqiang
    Shao, Jianyong
    Li, Li
    Ma, Jun
    PLOS ONE, 2014, 9 (10):
  • [3] Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Wu, Shixiu
    Xia, Bing
    Han, Fei
    Xie, Ruifei
    Song, Tao
    Lu, Lixia
    Yu, Wei
    Deng, Xiaowu
    He, Qiancheng
    Zhao, Cong
    Xie, Conghua
    PLOS ONE, 2015, 10 (08):
  • [4] Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
    Pan, Xin-Bin
    Liu, Yang
    Li, Ling
    Qu, Song
    Chen, Long
    Liang, Shi-Xiong
    Chen, Kai-Hua
    Liang, Zhong-Guo
    Zhu, Xiao-Dong
    AGING-US, 2020, 12 (02): : 1838 - 1847
  • [5] A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma
    Yuxiang He
    Qin Zhou
    Lin Shen
    Yajie Zhao
    Mingjun Lei
    Rui Wei
    Liangfang Shen
    Shousong Cao
    Radiation Oncology, 10
  • [6] A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma
    He, Yuxiang
    Zhou, Qin
    Shen, Lin
    Zhao, Yajie
    Lei, Mingjun
    Wei, Rui
    Shen, Liangfang
    Cao, Shousong
    RADIATION ONCOLOGY, 2015, 10
  • [7] Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    Yuan Zhang
    Wen-Fei Li
    Lei Chen
    Yan-Ping Mao
    Rui Guo
    Fan Zhang
    Hao Peng
    Li-Zhi Liu
    Li Li
    Qing Liu
    Jun Ma
    Scientific Reports, 5
  • [8] Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    Zhang, Yuan
    Li, Wen-Fei
    Chen, Lei
    Mao, Yan-Ping
    Guo, Rui
    Zhang, Fan
    Peng, Hao
    Liu, Li-Zhi
    Li, Li
    Liu, Qing
    Ma, Jun
    SCIENTIFIC REPORTS, 2015, 5
  • [9] Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Feng, Yanru
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    CANCER RESEARCH AND TREATMENT, 2019, 51 (03): : 1222 - 1230
  • [10] The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study
    Xu, Mengting
    Wang, Liuling
    Ding, Jianming
    Xu, Yiying
    Fei, Zhaodong
    BMC CANCER, 2025, 25 (01)